Smart Pills Market to Reach $1.73 Billion by 2035

Smart Pills Market is projected to grow from $0.83 billion in 2025 to $1.73 billion by 2035, registering a CAGR of 11.5% during the forecast period. The market is witnessing steady expansion driven by advancements in digital healthcare technologies, rising demand for minimally invasive diagnostic procedures, and increasing adoption of ingestible sensors for patient monitoring and drug delivery. A key macro driver accelerating market growth is the rising global burden of gastrointestinal (GI) disorders and chronic diseases. According to the World Health Organisation (WHO), digestive diseases are among the leading causes of morbidity globally, while the U.S. Food and Drug Administration (FDA) reports increasing approvals and adoption of capsule endoscopy devices due to their non-invasive nature. Additionally, data from IQVIA highlights the growing adoption of digital therapeutics and connected health devices, with global digital health investments exceeding $40 billion annually in recent years. These trends directly support the expansion of smart pills, particularly in diagnostics and remote patient monitoring.

Browse the full report description of “Smart Pills Market Size, Share & Trends Analysis Report, By Product Type (Capsule Endoscopy (Small Bowel Capsule, Colon Capsule, Esophageal Capsule), Drug Delivery Smart Pills (Controlled Release Capsules, Targeted Drug Delivery Capsules), and Patient Monitoring Smart Pills (Ingestible Sensors, Medication Adherence Pills)), By Technology (Imaging Technology (CMOS Sensors, Optical Imaging Systems), Sensor-Based Technology (pH, Temperature, Pressure Sensors), Wireless Communication Technology (RF Transmission, Bluetooth Systems), and Microelectronics & Miniaturization (Micro-batteries, Integrated Circuits)), By Application (Gastrointestinal Diagnostics (Crohn’s Disease, GI Bleeding, Tumour Detection), Drug Delivery & Therapeutics (Oncology, Neurology, Chronic Disease), and Patient Monitoring), and By Disease Indication (Gastrointestinal, Neurological, Oncology, Infectious, and Metabolic Disorders), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/smart-pills-market

The integration of advanced technologies such as CMOS sensors, wireless communication systems, and microelectronics is further enhancing the capabilities of smart pills. Sensor-based technologies, including pH and temperature sensors, are enabling real-time physiological monitoring, while Bluetooth-based systems are improving patient compliance and remote healthcare delivery. These technological advancements, combined with increasing healthcare expenditure and supportive regulatory frameworks, are expected to sustain long-term market growth. From an application perspective, gastrointestinal diagnostics remains a dominant segment, supported by increasing screening rates for Crohn’s disease, obscure GI bleeding, and tumour detection. The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) emphasises the rising global focus on early disease detection and precision medicine, further boosting demand for advanced ingestible diagnostic tools. Moreover, increasing healthcare digitisation, supported by organisations such as the International Telecommunication Union (ITU), is enhancing connectivity in smart medical devices, enabling real-time data transmission and analysis. Among product types, Capsule Endoscopy is emerging as the fastest-growing segment due to its widespread adoption in non-invasive GI diagnostics. Several strategic developments have further strengthened the market landscape. Key industry developments include:

• In May 2025, AnX Robotica Corporation obtained FDA 510(k) clearance for its MotiliCap™ GI monitoring system and companion MotiliScan™ software, positioning itself as a successor to Medtronic’s discontinued SmartPill® platform. This strategic move aims to capture the gap in the GI motility diagnostics market by offering enhanced pressure, pH, and temperature-based data capabilities along with a smartphone-enabled workflow, strengthening its presence in smart pill ecosystems and GI diagnostic devices.

• In early 2025, CapsoVision received FDA clearance for its CapsoCam Plus® capsule endoscopy system for pediatric use in children aged two and above. This expansion from adult-only applications enables the company to address a wider patient base by offering a non-invasive, child-friendly alternative to traditional endoscopy, thereby enhancing adoption, improving patient experience, and strengthening its competitive positioning in the capsule endoscopy segment.

Market Coverage

• The market number available for – 2025-2035
  • Base year- 2025
  • Forecast period- 2026-2035
  • Segment Covered-
  o By Product Type
  o By Application
  o By Technology
  o By Disease Indication
  • Competitive Landscape – Medtronic, Olympus Corporation, CapsoVision, Inc., etectRx, IntroMedic Co.

Key questions addressed by the report

• What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • Who is the leader in the market?
  • How are players addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Smart Pills Market Report Segment

By Product Type

• Capsule Endoscopy
  o Small Bowel Capsule
  o Colon Capsule
  o Esophageal Capsule
  • Drug Delivery Smart Pills
  o Controlled Release Capsules
  o Targeted Drug Delivery Capsules
  • Patient Monitoring Smart Pills
  o Ingestible Sensors (Vital Monitoring)
  o Medication Adherence Tracking Pills

By Technology

• Imaging Technology
  o CMOS Sensors
  o Optical Imaging Systems
  • Sensor-Based Technology
  o pH Sensors
  o Temperature Sensors
  o Pressure Sensors
  • Wireless Communication Technology
  o RF Transmission
  o Bluetooth-Based Systems
  • Microelectronics & Miniaturization
  o Micro-batteries
  o Integrated Circuits

By Application

• Gastrointestinal (GI) Diagnostics
  o Crohn’s Disease
  o Obscure GI Bleeding
  o Tumour Detection
  • Drug Delivery & Therapeutics
  o Oncology
  o Neurology
  o Chronic Disease Management
  • Patient Monitoring
  o Medication Adherence
  o Vital Signs Monitoring

By Disease Indication

• Gastrointestinal Disorders
  • Neurological Disorders
  • Oncology
  • Infectious Diseases
  • Metabolic Disorders

Global Smart Pills Market Report Segment by Region

North America

• United States
  • Canada

Europe

• UK
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe

Asia-Pacific

• China
  • India
  • Japan
  • South Korea
  • Australia and New Zealand
  • ASEAN Economies
  • Rest of Asia-Pacific

Rest of the World

• Latin America
  • Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/smart-pills-market